Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical distribution device

a technology for distribution devices and drugs, applied in the direction of transportation and packaging, packaging goods types, other domestic objects, etc., can solve the problems of reducing the efficacy of treatment, unable to adequately and positively identify the drugs and ancillary devices to be used in the regimen, and difficulty in following the order, dosage and timing of the drugs to be taken during fertility treatmen

Inactive Publication Date: 2005-07-14
MEDSTEP HEALTH SERVICES
View PDF21 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0010] Another aspect of the invention provides a kit for a complex drug regimen. In a preferred embodiment the kit includes: a kit container comprising a plurality of drug compartments, each drug compartment adapted to contain one or more drugs; a plurality of different drugs disposed in the drug compartments; and drug identification information visually associated with each drug compartment containing a drug. In some embodiments, the kit includes at least one label identifying drugs to be taken together. For example, if at least two of the drugs are intended to be used together, both may be associated with the label. In some embodiments the kit also includes at least one drug delivery tool disposed in a drug delivery compartment along with a drug, such as by placing the drug and its corresponding tool in an order of use within the drug compartment.

Problems solved by technology

Mistakes in the manner, order and / or dosage of fertility drugs may result in a reduced efficacy of the treatment.
One drawback of this and other prior art complex drug regimen kits is their failure to adequately and positively identify the drugs and ancillary devices to be used in the regimen.
For example, the order, dosage and timing of the drugs to be taken during fertility treatments can be difficult to follow.
While the fertility kit described in the Koestermann et al. patent application provides a prescription, orders or instructions, the kit does not sufficiently tie drug names or other identification information to the corresponding drugs, nor does it tie ancillary devices, such as syringes, to the drugs to which they correspond.
Psychological stress from uncertainty about which drugs and / or drug devices in the Koestermann fertility kit to use at a particular point in the treatment regimen, as well as actual treatment errors from choosing the wrong drug or device, can lead to reduced treatment efficacy.
Another drawback of earlier complex drug regimen kits is their relative inadaptability to changes in the drug regimen, such as changes to the drug contents, container sizes, etc.
This approach to constructing the kit is unduly inflexible and cumbersome.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical distribution device
  • Pharmaceutical distribution device
  • Pharmaceutical distribution device

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures, within the scope of these claims and their equivalents be covered thereby.

[0021]FIG. 1 shows one embodiment of the invention. A complex drug regimen kit 10, such as a kit containing drugs for fertility treatment, contains drugs 12, drug delivery devices 14 and other drug regimen materials arranged in drug compartments 16 formed within a box 18 or other container. The drug compartments are preferably arra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
dimensionaaaaaaaaaa
psychological stressaaaaaaaaaa
Login to View More

Abstract

A method of providing items required for a complex drug regimen. In a preferred embodiment the method includes the steps of disposing a plurality of different drugs in corresponding drug compartments within a container; and providing drug identification information visually associated with each drug compartment containing a drug. The invention also includes a kit for a complex drug regimen. In a preferred embodiment the kit includes a kit container including a plurality of drug compartments, each drug compartment adapted to contain a drug; a plurality of different drugs disposed in the drug compartments; and drug identification information visually associated with each drug compartment containing a drug.

Description

BACKGROUND OF THE INVENTION [0001] The invention relates generally to kits for complex drug regimens and methods of providing complex drug regimen items, such as methods and kits for fertility treatment regimens. [0002] Fertility enhancement treatment requires the self-administration of a variety of drugs in a prescribed manner, order and dosage according to a specified schedule. Mistakes in the manner, order and / or dosage of fertility drugs may result in a reduced efficacy of the treatment. [0003] More significantly, the psychological stress level of the woman undergoing fertility enhancement treatment can affect the outcome of the treatment. Higher levels of psychological stress have been linked to reduced positive outcomes. See, e.g., “DeStress for (Fertility) Success,” HealthScoutNews Jun. 29, 2001; “What Is the Stress / Infertility Connection?”, an online chat dated Jun. 2, 2003 and viewable at http: / / www.resolve.org / main / national / bboard / chat030602.jsp. [0004] Koestermann et al. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61J7/00B65D69/00
CPCA61J2205/00A61J7/0084
Inventor PILE, NANCY G.
Owner MEDSTEP HEALTH SERVICES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products